Company Filing History:
Years Active: 2013-2014
Title: Younis Baqi: Innovator in GPR17 Research
Introduction
Younis Baqi is a notable inventor based in Bonn, Germany. He has made significant contributions to the field of biological research, particularly in the study of GPR17. With a total of 2 patents, his work focuses on innovative methods for determining the biological activity of GPR17.
Latest Patents
Younis Baqi's latest patents include advancements in GPR17 agonists and screening assays. The first patent relates to a method for determining a test compound's ability to modify the biological activity of GPR17. This method involves contacting the test compound with GPR17 or a functional GPR17 fragment in the presence of a suitable amount of a GPR17 agonist of formula I. The second patent also focuses on identifying modulators of GPR17 using a similar approach.
Career Highlights
Throughout his career, Younis Baqi has worked at prestigious institutions, including Rheinische Friedrich-Wilhelms-Universität Bonn. His research has contributed to a deeper understanding of GPR17 and its potential applications in various fields.
Collaborations
Younis has collaborated with esteemed colleagues such as Evi Kostenis and Andreas Spinrath, further enhancing the impact of his research.
Conclusion
Younis Baqi's innovative work in GPR17 research exemplifies the importance of scientific inquiry and collaboration in advancing our understanding of biological processes. His contributions continue to influence the field and inspire future research endeavors.